Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Lu, Miaomiao ^a   Yin, Nanchang ^a   Liu, Wei ^a   Cui, Xiangfei ^a   Chen, Shuo ^a   Wang, Ermin ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; COLLAGEN TYPE 4; CRYOPYRIN; CURCUMIN; FIBRONECTIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; IL1B PROTEIN, MOUSE; INFLAMMASOME; NLRP3 PROTEIN, MOUSE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; EXTRACELLULAR MATRIX; MESANGIUM; METABOLISM; PATHOLOGY;

ANIMALS; CASPASE 1; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; INFLAMMASOMES; INTERLEUKIN-1BETA; MALE; MICE; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; SIGNAL TRANSDUCTION;

EID: 85011586188     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/1516985     Document Type: Article

References (33)

1. R. Patil, A. Nasrin Nisha, S. S. Datta, A. V. Boratne, and Lokeshmaran, "Popular misconceptions regarding the diabetes management: where should we focus our attention?" Journal of Clinical and Diagnostic Research, vol. 7, no. 2, pp. 287-291, 2013.
2. A. J. Collins, R. N. Foley, B. Chavers et al., "United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States," American Journal of Kidney Diseases, vol. 59, no. 1, supplement 1, p. A7, 2011.
3. H. Gallagher and R. J. Suckling, "Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?" Diabetes, Obesity and Metabolism, vol. 18, no. 7, pp. 641-647, 2016.
4. E. J. Lewis and J. B. Lewis, "Treatment of diabetic nephropathy with angiotensin II receptor antagonist," Clinical and Experimental Nephrology, vol. 7, no. 1, pp. 1-8, 2003.
5. F. R. Danesh, M. M. Sadeghit, N. Amro et al., "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucoseinduced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8301-8305, 2002.
6. S. A. Johnson and R. F. Spurney, "Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy," American Journal of Physiology - Renal Physiology, vol. 309, no. 10, pp. F807-F820, 2015.
7. G. Remuzzi, P. Ruggenenti, A. Perna et al., "Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results," Journal of theAmerican Society of Nephrology, vol. 15, no. 12, pp. 3117-3125, 2004.
8. N.M. Elsherbiny and M. M. H. Al-Gayyar, "The role of IL-18 in type 1 diabetic nephropathy: the problemand future treatment," Cytokine, vol. 81, pp. 15-22, 2016.
9. Y.-J. Surh and K.-S. Chun, "Cancer chemopreventive effects of curcumin," Advances in ExperimentalMedicine and Biology, vol. 595, pp. 149-172, 2007.
10. E. Balogun, M. Hoque, P. Gong et al., "Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element," Biochemical Journal, vol. 371, no. 3, pp. 887-895, 2003.
11. H. He, G.-Y.Wang, Y. Gao,W.-H. Ling, Z.-W. Yu, and T.-R. Jin, "Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice," World Journal of Diabetes, vol. 3, no. 5, pp. 94-104, 2012.
12. S. S. Ghosh, H.D.Massey,R.Krieg et al., "Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation," American Journal of Physiology - Renal Physiology, vol. 296, no. 5, pp. F1146-F1157, 2009.
13. S. Ghosh, S. Banerjee, and P. C. Sil, "The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update," Food and Chemical Toxicology, vol. 83, pp. 111-124, 2015.
14. K. Chen, J. Zhang, W. Zhang et al., "ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy," International Journal of Biochemistry and Cell Biology, vol. 45, no. 5, pp. 932-943, 2013.
15. K. Schroder and J. Tschopp, "The Inflammasomes," Cell, vol. 140, no. 6, pp. 821-832, 2010.
16. C. Wang, Y. Pan, Q.-Y. Zhang, F.-M. Wang, and L.-D. Kong, "Quercetin and allopurinol ameliorate kidney injury in STZtreated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation," PLoS ONE, vol. 7, no. 6,Article ID e38285, 2012.
17. A. Vilaysane, J. Chun, M. E. Seamone et al., "The NLRP3 inflammasome promotes renal inflammation and contributes to CKD," Journal of theAmerican Society of Nephrology, vol. 21, no. 10, pp. 1732-1744, 2010.
18. A. A. Shigeoka, J. L. Mueller, A. Kambo et al., "An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury," Journal of Immunology, vol. 185, no. 10, pp. 6277-6285, 2010.
19. K. Sharma, P.McCue, and S. R. Dunn, "Diabetic kidney disease in the db/db mouse," American Journal of Physiology - Renal Physiology, vol. 284, no. 6, pp. F1138-F1144, 2003.
20. L. H. Wang, J. S. Liu, W. B. Ning et al., "Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice," Pharmacology, vol. 88, no. 1-2, pp. 88-99, 2011.
21. X. Xiong,W.Mei, Y. Xie et al., "Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways," PLOS ONE, vol. 9, no. 10, Article ID e111242, 2014.
22. G. N. Roth, A. Chandra, and M. G. Nair, "Novel bioactivities of Curcuma longa constituents," Journal of Natural Products, vol. 61, no. 4, pp. 542-545, 1998.
23. S. Prasad, S. C. Gupta, A. K. Tyagi, and B. B. Aggarwal, "Curcumin, a component of golden spice: from bedside to bench and back," Biotechnology Advances, vol. 32, no. 6, pp. 1053-1064, 2014.
24. P. Suresh Babu and K. Srinivasan, "Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats," Molecular and Cellular Biochemistry, vol. 181, no. 1-2, pp. 87-96, 1998.
25. S. Sharma, S. K. Kulkarni, and K. Chopra, "Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats," Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 10, pp. 940-945, 2006.
26. K. Tikoo, R. L.Meena,D. G. Kabra, andA. B.Gaikwad, "Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy," British Journal of Pharmacology, vol. 153, no. 6, pp. 1225-1231, 2008.
27. J.Chiu, Z. A. Khan,H.Farhangkhoee, andS.Chakrabarti, "Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB," Nutrition, vol. 25, no. 9, pp. 964-972, 2009.
28. S. P. RamachandraRao, Y. Zhu, T. Ravasi et al., "Pirfenidone is renoprotective in diabetic kidney disease," Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1765-1775, 2009.
29. Z. Gong, J. Zhou, H. Li et al., "Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock," Molecular Nutrition and Food Research, vol. 59, no. 11, pp. 2132-2142, 2015.
30. H.-J. Anders and D. A.Muruve, "The inflammasomes in kidney disease," Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 1007-1018, 2011.
31. G. Lorenz, M. N. Darisipudi, and H.-J. Anders, "Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis," Nephrology Dialysis Transplantation, vol. 29, no. 1, pp. 41-48, 2014.
32. M. Correa-Costa, T. T. Braga, P. Semedo et al., "Pivotal role of toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis," PLoS ONE, vol. 6, no. 12, Article IDe29004, 2011.
33. F. Barutta, G. Bruno, S. Grimaldi, and G. Gruden, "Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment," Endocrine, vol. 48, no. 3, pp. 730-742, 2015.